Connection
Tamara Perry to Adolescent
This is a "connection" page, showing publications Tamara Perry has written about Adolescent.
|
|
Connection Strength |
|
 |
|
 |
|
0.711 |
|
|
|
-
He X, Bian J, Berlinski A, Guo Y, Simmons AL, Marshall SA, Greene CJ, Brown RH, Turner J, Perry TT. Mobile Health App for Adolescent Asthma Self-Management: Development and Usability Study of the Pulmonary Education and Knowledge Mobile Asthma Action Plan. JMIR Form Res. 2025 Apr 24; 9:e64212.
Score: 0.124
-
Perry TT, Grant TL, Dantzer JA, Udemgba C, Jefferson AA. Impact of socioeconomic factors on allergic diseases. J Allergy Clin Immunol. 2024 02; 153(2):368-377.
Score: 0.112
-
Ararat E, Landes RD, Forno E, Tas E, Perry TT. Metformin use is associated with decreased asthma exacerbations in adolescents and young adults. Pediatr Pulmonol. 2024 Jan; 59(1):48-54.
Score: 0.111
-
Burbank AJ, Lewis SD, Hewes M, Schellhase DE, Rettiganti M, Hall-Barrow J, Bylander LA, Brown RH, Perry TT. Mobile-based asthma action plans for adolescents. J Asthma. 2015; 52(6):583-6.
Score: 0.063
-
Pesek RD, Vargas PA, Halterman JS, Jones SM, McCracken A, Perry TT. A comparison of asthma prevalence and morbidity between rural and urban schoolchildren in Arkansas. Ann Allergy Asthma Immunol. 2010 Feb; 104(2):125-31.
Score: 0.043
-
Perry TT, Vargas PA, McCracken A, Jones SM. Underdiagnosed and uncontrolled asthma: findings in rural schoolchildren from the Delta region of Arkansas. Ann Allergy Asthma Immunol. 2008 Oct; 101(4):375-81.
Score: 0.039
-
Perry TT, Wood RA, Matsui EC, Curtin-Brosnan J, Rand C, Eggleston PA. Room-specific characteristics of suburban homes as predictors of indoor allergen concentrations. Ann Allergy Asthma Immunol. 2006 Nov; 97(5):628-35.
Score: 0.034
-
Boyd M, Eyimina A, Brown CC, Goudie A, Ararat E, Rezaeiahari M, Perry TT, Tilford JM, Jefferson AA. Association of Allergy Specialty Care and Asthma Outcomes for Medicaid-Enrolled Children. J Pediatr. 2025 Feb; 277:114361.
Score: 0.030
-
O'Sullivan B, Ounpraseuth S, James L, Majure M, Lang J, Hu Z, Simon A, Bickel S, Ely B, Faricy LE, Garza M, Greer M, Hsia D, Jefferson A, Knight L, Lee J, Liptzin D, Haktanir Abul M, Perry TT, Prior F, SanGiovanni C, Tam-Williams J, Wu B, Snowden J. Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial. Clin Pharmacol Ther. 2024 02; 115(2):231-238.
Score: 0.028
-
Kim EH, Perry TT, Wood RA, Leung DYM, Berin MC, Burks AW, Cho CB, Jones SM, Scurlock A, Sicherer SH, Henning AK, Dawson P, Lindblad RW, Plaut M, Sampson HA. Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy. J Allergy Clin Immunol. 2020 10; 146(4):851-862.e10.
Score: 0.022
-
Pesek RD, Rettiganti M, O'Brien E, Beckwith S, Daniel C, Luo C, Scurlock AM, Chandler P, Levy RA, Perry TT, Kennedy JL, Chervinskiy S, Vonlanthen M, Casteel H, Fiedorek SC, Gibbons T, Jones SM. Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2017 08; 119(2):177-183.
Score: 0.018
-
Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP. Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol. 2017 Mar; 139(3):882-888.e5.
Score: 0.017
-
Sidhu N, Jones S, Perry T, Thompson T, Storm E, Melguizo Castro MS, Nick TG. Evaluation of Anaphylaxis Management in a Pediatric Emergency Department. Pediatr Emerg Care. 2016 Aug; 32(8):508-13.
Score: 0.017
-
Song Y, Wang J, Leung N, Wang LX, Lisann L, Sicherer SH, Scurlock AM, Pesek R, Perry TT, Jones SM, Li XM. Correlations between basophil activation, allergen-specific IgE with outcome and severity of oral food challenges. Ann Allergy Asthma Immunol. 2015 Apr; 114(4):319-26.
Score: 0.015
-
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014 Feb; 133(2):468-75.
Score: 0.014
-
Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011 Mar; 127(3):654-60.
Score: 0.012
-
Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, Francis JM, Durham S, Vickery BP, Zhong X, Burks AW. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol. 2009 Aug; 124(2):292-300, 300.e1-97.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|